Physicians Realty Trust (DOC) Expected to Post Quarterly Sales of $104.36 Million

Wall Street brokerages expect Physicians Realty Trust (NYSE:DOC) to announce sales of $104.36 million for the current fiscal quarter, according to Zacks. Seven analysts have made estimates for Physicians Realty Trust’s earnings, with the lowest sales estimate coming in at $101.20 million and the highest estimate coming in at $106.60 million. Physicians Realty Trust posted sales of $76.60 million during the same quarter last year, which suggests a positive year-over-year growth rate of 36.2%. The company is expected to issue its next quarterly earnings report on Thursday, August 2nd.

On average, analysts expect that Physicians Realty Trust will report full-year sales of $420.83 million for the current financial year, with estimates ranging from $412.80 million to $428.47 million. For the next financial year, analysts forecast that the firm will post sales of $434.92 million per share, with estimates ranging from $423.00 million to $455.89 million. Zacks Investment Research’s sales averages are an average based on a survey of sell-side research firms that follow Physicians Realty Trust.

Physicians Realty Trust (NYSE:DOC) last issued its quarterly earnings results on Friday, May 4th. The real estate investment trust reported $0.06 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.27 by ($0.21). The company had revenue of $105.20 million during the quarter, compared to analyst estimates of $101.70 million. Physicians Realty Trust had a net margin of 11.46% and a return on equity of 1.75%. The business’s revenue was up 37.2% on a year-over-year basis. During the same quarter last year, the firm earned $0.28 EPS.



Several research firms have issued reports on DOC. Zacks Investment Research cut Physicians Realty Trust from a “hold” rating to a “sell” rating in a research report on Tuesday, January 30th. Cantor Fitzgerald reiterated a “buy” rating and set a $18.00 target price on shares of Physicians Realty Trust in a research report on Monday, May 7th. Morgan Stanley dropped their target price on Physicians Realty Trust from $18.00 to $16.50 and set an “equal weight” rating on the stock in a research report on Tuesday, March 20th. Bank of America dropped their target price on Physicians Realty Trust from $19.50 to $18.00 and set a “buy” rating on the stock in a research report on Thursday, March 8th. Finally, KeyCorp dropped their target price on Physicians Realty Trust from $20.00 to $17.00 and set a “buy” rating on the stock in a research report on Tuesday, April 17th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and ten have issued a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus target price of $17.96.

Physicians Realty Trust traded up $0.08, hitting $14.96, during trading on Friday, MarketBeat reports. The company had a trading volume of 728,315 shares, compared to its average volume of 1,547,041. The stock has a market capitalization of $2.71 billion, a PE ratio of 14.38, a price-to-earnings-growth ratio of 3.13 and a beta of 0.46. Physicians Realty Trust has a 1-year low of $14.13 and a 1-year high of $21.85. The company has a quick ratio of 1.39, a current ratio of 1.39 and a debt-to-equity ratio of 0.63.

In other news, Director Tommy G. Thompson purchased 13,650 shares of the stock in a transaction that occurred on Tuesday, March 6th. The shares were acquired at an average price of $14.71 per share, for a total transaction of $200,791.50. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 0.51% of the company’s stock.

Several institutional investors and hedge funds have recently added to or reduced their stakes in DOC. Ceredex Value Advisors LLC acquired a new stake in shares of Physicians Realty Trust in the 1st quarter worth approximately $68,578,000. Brookfield Asset Management Inc. acquired a new stake in shares of Physicians Realty Trust in the 4th quarter worth approximately $70,764,000. Cbre Clarion Securities LLC acquired a new stake in shares of Physicians Realty Trust in the 4th quarter worth approximately $46,085,000. PGGM Investments grew its holdings in shares of Physicians Realty Trust by 69.0% in the 4th quarter. PGGM Investments now owns 4,604,000 shares of the real estate investment trust’s stock worth $82,826,000 after acquiring an additional 1,880,000 shares during the period. Finally, Uniplan Investment Counsel Inc. acquired a new stake in shares of Physicians Realty Trust in the 1st quarter worth approximately $14,136,000. Institutional investors and hedge funds own 93.22% of the company’s stock.

About Physicians Realty Trust

Physicians Realty Trust is a self-managed healthcare real estate company organized to acquire, selectively develop, own and manage healthcare properties that are leased to physicians, hospitals and healthcare delivery systems. The Company invests in real estate that is integral to providing high quality healthcare.

Get a free copy of the Zacks research report on Physicians Realty Trust (DOC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Physicians Realty Trust (NYSE:DOC)

Receive News & Ratings for Physicians Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physicians Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply